NCT04549324View on ClinicalTrials.gov

Sleep Apnea, Coronary Atherosclerosis and Heart Failure in Diabetes Patients With Nephropathy

CompletedOBSERVATIONAL
Enrollment

74

Participants

Timeline

Start Date

October 1, 2020

Primary Completion Date

January 24, 2022

Study Completion Date

January 24, 2022

Conditions
Sleep ApneaDiabetic Nephropathy Type 2Coronary AtherosclerosesHeart InsufficiencyArterial StiffnessKidney DiseasesVascular Diseases
Trial Locations (1)

8200

Aarhus University Hospital, Aarhus

All Listed Sponsors
lead

University of Aarhus

OTHER

NCT04549324 - Sleep Apnea, Coronary Atherosclerosis and Heart Failure in Diabetes Patients With Nephropathy | Biotech Hunter | Biotech Hunter